We are live on ! Find out more
KIN

Kindred Biosciences
KIN

Delisted

KIN was delisted on the 27th of August, 2021.

39 hedge funds and large institutions have $157M invested in Kindred Biosciences in 2014 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

238% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 8

95% more funds holding

Funds holding: 20 → 39 (+19)

56% more capital inflows, than outflows

Capital inflows: $30.3M | Capital outflows: $19.5M

43.01% more ownership

Funds ownership: 0% → 43.01% (+43%)

29% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 7

Holders
39
Holders Change
+19
Holders Change %
+95%
% of All Funds
1.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
27
Increased
5
Reduced
7
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

KIN Hedge Fund Activity: Q1 2014 in Review

39 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in Kindred Biosciences (KIN) for Q1 2014, worth a combined $157M — up 71% from $91.5M a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new KIN positions and 8 closed out — a net gain of 19 holders — while 5 added to existing stakes and 7 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $5.04M. The largest seller was Adage Capital Partners, cutting an estimated $5.24M.

  • 39 institutional investors held Kindred Biosciences (KIN) as of Q1 2014, up from 20 in Q4 2013.
  • Funds reported $157M of Kindred Biosciences stock for Q1 2014, up 71% quarter-over-quarter.
  • 27 funds opened new Kindred Biosciences positions in Q1 2014 and 8 closed out, a net change of +19 holders.
  • The largest Kindred Biosciences buyer in Q1 2014 was Fidelity Investments, an estimated $5.04M added.
  • The largest Kindred Biosciences seller in Q1 2014 was Adage Capital Partners, an estimated $5.24M sold.

Based on aggregated 13F filings for Q1 2014.